Pancreatic cancer is diagnosed in over 124,000 individuals globally per year and is nearly uniformly fatal in the developing and developed areas, with the lowest overall 5-year survival rate of all site-specific cancers [1, 2]. The lethality of pancreatic cancer requires dedicated attention to understanding the causes and modifiable risk factors associated with development of this disease.
